Investments

MANAGER INSIGHTS

Opportunities and inefficiencies: How activist hedge fund Bluebell Capital is reaping rewards with large-cap Euro focus

Opportunities and inefficiencies: How activist hedge fund Bluebell Capital is reaping rewards with large-cap Euro focus

Founded by a team of Italian former investment bankers, London-based activist hedge fund Bluebell Capital Partners has gained impressive momentum over the past year with its focus on listed, predominantly European large-cap companies.

OUTLOOK

JP Morgan Asset Management forecasts “rich environment” for hedge funds as ‘megatrends’ take centre-stage

JP Morgan Asset Management forecasts “rich environment” for hedge funds as ‘megatrends’ take centre-stage

The fallout from the coronavirus pandemic is set to unlock global “megatrends” this year, including consumer and corporate technology, healthcare, and sustainability themes – and hedge fund investors can expect a “rich environment for growth”, a major new study by JP Morgan Asset Management suggests.

BREXIT

Brexit talks: Hedge funds warn of extreme volatility amid risk of “accidental” No Deal

Brexit talks: Hedge funds warn of extreme volatility amid risk of “accidental” No Deal

London-based hedge funds are warning of renewed market uncertainty, a less bullish stance on the pound and “extreme volatility” in the coming days, after EU Commission president Ursula von der Leyen and UK prime minister Boris Johnson agreed to further extend Brexit negotiations – with the risk of an “accidental” No Deal exit still remaining live.

SHORT-SELLING

UK hedge fund Argonaut takes aim at AstraZeneca-Oxford vaccine and warns against “silver bullet” recovery

UK hedge fund Argonaut takes aim at AstraZeneca-Oxford vaccine and warns against “silver bullet” recovery

The recent stock market “exuberance” sparked off by breakthroughs in Covid-19 vaccine trials may give way to disappointment next year, says Argonaut Capital CEO and CIO Barry Norris, who continues to build short positions in a number of drug companies, including AstraZeneca, amid continued uncertainty over efficacy and dosage in its trial process.

MANAGER INSIGHTS

“We go where the ideas are”: Emerging market hedge fund Pembroke gathers pace with fundamental focus

“We go where the ideas are”: Emerging market hedge fund Pembroke gathers pace with fundamental focus

Since launching in early 2018, Pembroke Emerging Markets – a London-based global long/short equity hedge fund led by former Goldman Sachs trader Sanjiv Bhatia – has capitalised on demographic shifts in emerging economies with a fundamental, bottom-up stock-picking style which uses convexity plays to boost alpha generation.